Summary
A number of small, randomised clinical trials and one large trial of intravenous magnesium have been conducted on patients with acute myocardial infarction (AMI). Most of these trials indicate that treatment with magnesium has a beneficial effect on short term mortality, although in most of the small trials the results are inconclusive.
A systematic overview of mortality and serious morbidity data from all the available randomised controlled trials of magnesium conducted in a total of nearly 4000 patients with AMI indicates that there were 123 deaths in 1974 patients allocated magnesium, and 193 deaths in 1949 controls (odds ratio 0.61, 95% confidence interval 0.48 to 0.76, p < 0.0001). Data on the effects of magnesium on serious ventricular arrhythmias and heart failure are incomplete, and definitions for these serious complications of AMI vary greatly among the trials. Nevertheless, the available data suggest that magnesium also significantly reduces these 2 serious forms of morbidity.
These data suggest that magnesium given to patients during AMI can produce significant reductions in mortality and serious morbidity. Although the mechanism of action of magnesium is likely to be independent of other currently used agents, its value when added to thrombolytic therapy, β-blockers, angiotensin converting enzyme (ACE) inhibitors and nitrates is not clear, and is presently being studied in the very large Fourth International Studies of Infarct Survival (ISIS-4) trial.
Similar content being viewed by others
References
Abraham AS, Rosenmann D, Kramer M, Balkin J, Zion MM, et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Archives of Internal Medicine 147: 753–755, 1987
Adams JH, Mitchell JRA. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo. Thrombosis and Haemostasis 42: 603–610, 1979
Altura BM, Altura BT. Influence of magnesium on drug induced contractions and ion content in rabbit aorta. American Journal of Physiology 220: 938–944, 1971
Barros LFM, Da-Luz PL, Silveira MC, Chagas ACP, Pileggi F. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate. Brazilian Journal of Medical and Biological Research 21: 791–799, 1988
Borchgrevink PC, Bergan AS, Bakoy OE, Jynge P. Magnesium and reperfusion of ischemic rat heart as assessed by 31P-NMR. American Journal of Physiology 256: H195–204, 1989
Ceremuzynski L, Jurgiel R, Kulakoswski P, Gebalska J. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. American Heart Journal 118: 1333–1334, 1989
Chang C, Varghese PJ, Downey J, Bloom S. Magnesium deficiency and myocardial infarct size in the dog. Journal of the American College of Cardiology 5: 280–289, 1985
Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systemic overviews. Statistics in Medicine 6: 245–250, 1987
Collins R, Julian D. British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. British Heart Journal 66: 259–264, 1991
Crampton RS, Clark CW. Varying extracellular (Mg2+) alters ischemic and reperfusion tachyarrhythmias. Abstract. Circulation 68 (Suppl. 3): III–146, 1983
Dyckner T. Serum magnesium in acute myocardial infarction. Relation to arrhythmias. Acta Medica Scandinavica 207: 59–66, 1980
Dyckner T, Wester PO. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. American Heart Journal 97: 12–18, 1979
Early Breast Cancer Trialists’ Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. New England Journal of Medicine 319: 1681–1692, 1988
Editorial. Magnesium for acute myocardial infarction? Lancet 338: 667–668, 1991
Elwood PC, Sweetnam PM, Beasley WH, Jones D, France R. Magnesium and calcium in the myocardium: cause of death and area differences. Lancet 2: 720–722, 1980
Favaron M, Bernardi P. Tissue-specific modulation of the mitochondrial calcium uniporter by magnesium ions. FEBS Letters 183: 260–264, 1985
Feldstedt M, Boesgaard S, Bouchelouche P, Svenningsen A, Brooks L, et al. Magnesium substitution in acute ischemic heart syndromes. European Heart Journal 12: 1215–1218, 1991
Ferrari R, Albertini A, Curello S, Ceconi C, Di Lisa F, et al. Myocardial recovery during post-ischemic reperfusion: effects of nifedipine, calcium and magnesium. Journal of Molecular and Cell Cardiology 18: 487–498, 1986
Ghani MF, Rabah M. Effect of magnesium chloride on electrical stability of the heart. American Heart Journal 94: 600–602, 1977
Haverkamp W, Hindricks G, Keteller T, Alberty D, Wiethold D, et al. Prophylactic antiarrhythmic and antifibrillatory effects of intravenous magnesium sulphate during acute myocardial ischemia. Abstract. European Heart Journal 9 (Suppl. 1): 227, 1988
Hearse DJ. Reperfusion of the ischemic myocardium. Journal of Molecular and Cell Cardiology 9: 605–616, 1977.
Heptinstall S, Lyne S, Mitchell JRA, Will EJ. Magnesium infusion in acute myocardial infarction. Lancet 1: 552, 1986
Hlatky MA, Cotugno HE, Mark DB, O’Connor C, Califf RM, et al. Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. American Journal of Cardiology 61: 515–518, 1988
Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation 86: 774–779, 1992
Iseri LT. Magnesium and dysrrhythmias. Magnesium Bulletin 8: 223–229, 1986
Kimura T, Yasue H, Sakaino N, Rokutanda M, Jougasaki M, et al. Effects of magnesium on the tone of isolated human coronary arteries. Circulation 79: 1118–1124, 1989
Kugiyama K, Yasua H, Okumura K, Goto K, Minoda K, et al. Suppression of exercise-induced angina by magnesium sulphate in patients with variant angina. Journal of the American College of Cardiology 12: 1177–1183, 1988
Leary WP, Reyes AJ, Lockett CJ, Arbuckle DD, Van der Ryl K. Magnesium and death ascribed to ischemic heart disease in South Africa. A preliminary report. South African Medical Journal 64: 775–776, 1983
Luoma H, Aromaa A, Helminen S, Murtomaa H, Kiviluoto L, et al. Risk of myocardial infarction in Finnish men in relation to fluoride, magnesium and calcium in drinking water. Acta Medica Scandinavica 213: 171–176, 1983
Mishra RK. Studies on experimental magnesium deficiencies in the albino rat. Functional and morphological changes associated with low intake of Mg. Revue Canadienne de Biologie 19: 122–135, 1960
Morton BC, Smith FM, McKibbon TG, Nair RC, Poznanski WJ. Magnesium therapy in acute myocardial infarction. Magnesium Bulletin 1: 192–194, 1981
Morton MC, Nair RC, Smith FM, McKibbon TG, Poznanski WJ. Magnesium therapy in acute myocardial infarction — a double blind study. Magnesium Bulletin 3: 346–352, 1984a
Morton BC, Smith FM, Nair RC, McKibbon TG, Poznanski WJ. The clinical effects of magnesium sulfate treatment in acute myocardial infarction. Magnesium Bulletin 4: 133–136, 1984b
Mroczek WJ, Lee WR, Davidov ME. Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology 28: 720–724, 1977
Nadler JL. Goodson S, Rude R. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 9: 379–383, 1987
Perticone F, Adinolfi L, Bonaduce D. Efficacy of magnesium sulfate in the treatment of torsades de pointes. American Heart Journal 112: 847–849, 1986
Peto R. Why do we need systemic overviews of randomized trials?. Statistics in Medicine 6: 233–240, 1987
Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, et al. Intravenous magnesium in acute myocardial infarction. Lancet 1: 234–236, 1986a
Rasmussen HS, Aurup P, Hojberg S, Jensen EK, McNair P. Magnesium and acute myocardial infarction: transient hypomagnesemia not induced by renal magnesium loss in patients with acute myocardial infarction. Archives of Internal Medicine 146: 872–874, 1986b
Rasmussen HS, Gronbaek M, Cintin C, Balslov S, Norregard P, McNair P. One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clinical Cardiology 11: 377–381, 1988
Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, et al. Magnesium therapy and mortality in acute myocardial infarction. American Journal of Cardiology 66: 271–274, 1990
Shechter M, Hod H. Magnesium therapy in aged patients with acute myocardial infarction. Magnesium Bulletin 13: 7–9, 1991
Shechter M, Hod H, Kaplinsky E, Rabinowitz B. Magnesium administration in patients with acute myocardial infarction who are not candidates for thrombolytic therapy. European Heart Journal 12: 401, 1991
Shine KI. Myocardial effects of magnesium. American Journal of Physiology 237: H413–423, 1979
Singh A, Uppal AK, Singh K. Serum magnesium and consumed water magnesium levels in cases of acute myocardial infarction and in controls. Indian Journal of Medical Sciences 37: 81–84, 1983
Singh RB, Sircar AR, Rastogi SS, Garg V. Magnesium and potassium administration in acute myocardial infarction. Magnesium and Trace Elements 9: 198–204, 1990
Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenous infusion of magnesium sulphate after myocardial infarction: effects on arrhythmias and mortality. International Journal of Cardiology 12: 175–180, 1986
Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. British Medical Journal 303: 1499–1503, 1991
Turlapaty PD, Altura BM. Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. European Journal of Pharmacology 52: 421–423, 1978
Turlapaty PDMV, Altura BM. Magnesium deficiency produces spasm of coronary arteries: relationship to aetiology of sudden death in ischemic heart disease. Science 208: 198–200, 1980
Tzivoni D, Banai S, Schuger C, Benhorin J, Keren AA, et al. Treatment of torsade de pointe with magnesium sulfate. Circulation 77: 393–397, 1988
Vigorito C, Giordano A, Ferraro P, Acanfora D, De Caprio L, et al. Hemodynamic effects of magnesium sulfate on the normal human heart. American Journal of Cardiology 67: 1435–1437, 1991
Watson KV, Moldow CF, Ogburn PL, Jacob HS. Magnesium sulfate: rationale for its use in pre-eclampsia. Proceedings of the National Academy of Sciences of the United States of America 83: 1075–1078, 1986
Woods KL. Possible pharmacological actions of magnesium in acute myocardial infarction. British Journal of Clinical Pharmacology 32: 2–10, 1991
Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339: 1553–1558, 1992
Yusuf S, Peto R, Lewis J, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases 17: 335–371, 1985
Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. Treatments following myocardial infarction. Journal of the American Medical Association 260: 2088–2093, 1988
Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. Circulation 82 (Suppl. 2): 117–134, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Teo, K.K., Yusuf, S. Role of Magnesium in Reducing Mortality in Acute Myocardial Infarction. Drugs 46, 347–359 (1993). https://doi.org/10.2165/00003495-199346030-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199346030-00002